Evidence map›Paper›PMID 31357768›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2019

[Toll-like receptor 4 in liver ischemia-reperfusion injury].

L Yang, H L Song

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. [Study of R2* value to evaluate regulation of liver regeneration by hepatic warm ischemia-reperfusion injury after partial hepatectomy in rabbits].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

L YangThe First Central Clinical College, Tianjin Medical University, Tianjin 300192, China.
H L SongDepartment of Organ Transplantaion, Tianjin First Central Hospital, Tianjin Key Laboratory of Organ Transplantation, Key Laboratory of Transplantation Medicine, Chinese Academy of Medical Sciences, Tianjin 300192, China.
Tianjin First Center Hospital · CNTianjin Medical University · CN

Funding

National Natural Science Foundation of China 81670574, 81270528, 81441022
6 · The paper itself

Abstract

Toll-like receptor 4 (TLR4) is a member of the toll-like receptor family and belongs to the family of pattern recognition receptors. The role of TLR4 signaling pathway in liver ischemia-reperfusion injury has been widely studied in recent years, and its control methods in inflammatory response is becoming the most important research hotspot. In this paper, the research progress of the molecules and their regulatory mechanisms involved with TLR4 signaling pathway in liver ischemia-reperfusion injury is reviewed, which act as a new foundation of clinical research to study the pathogenic mechanisms and treatment plan.

Indexed as

Reperfusion InjurySignal TransductionToll-Like Receptor 4HumansLiverToll-Like Receptor 4Hepatic ischemia reperfusion injurySignaling pathwayToll-like receptor 4

Identifiers

PMID31357768
PMCPMC12769264
OpenAlexW2996364637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.